|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 280.74 USD | +0.75% |
|
+1.96% | +1.92% |
| 04:39pm | Jefferies Adjusts Price Target on Cigna Group to $330 From $333, Maintains Buy Rating | MT |
| 15/04 | Baird Adjusts Cigna Price Target to $306 From $315, Maintains Outperform Rating | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 17TCr | 18TCr | 19TCr | 25TCr | 27TCr | |||||
Gain (Loss) on Sale of Investment, Total (Rev) | - | - | - | - | - | |||||
Interest And Invest. Income (Rev) | 154.9Cr | 115.5Cr | 116.6Cr | 97Cr | 104.6Cr | |||||
Total Revenues | 17TCr | 18TCr | 20TCr | 25TCr | 27TCr | |||||
Cost of Goods Sold, Total | 15TCr | 16TCr | 17TCr | 22TCr | 25TCr | |||||
Gross Profit | 2.3TCr | 2.35TCr | 2.52TCr | 2.6TCr | 2.56TCr | |||||
Selling General & Admin Expenses, Total | 1.28TCr | 1.31TCr | 1.44TCr | 1.46TCr | 1.36TCr | |||||
Stock-Based Compensation (IS) | - | - | - | - | - | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 199.8Cr | 187.6Cr | 181.9Cr | 170.3Cr | 174.3Cr | |||||
Other Operating Expenses | - | - | - | - | - | |||||
Other Operating Expenses, Total | 1.48TCr | 1.5TCr | 1.62TCr | 1.63TCr | 1.53TCr | |||||
Operating Income | 815.6Cr | 847.8Cr | 898.8Cr | 969.2Cr | 1.03TCr | |||||
Interest Expense, Total | -111.9Cr | -116.3Cr | -140Cr | -150Cr | -140Cr | |||||
Net Interest Expenses | -111.9Cr | -116.3Cr | -140Cr | -150Cr | -140Cr | |||||
Other Non Operating Income (Expenses) | - | - | - | 6.5Cr | -80L | |||||
EBT, Excl. Unusual Items | 703.7Cr | 731.5Cr | 758.8Cr | 825.7Cr | 885.1Cr | |||||
Restructuring Charges | -17Cr | -2.2Cr | -25Cr | - | -75Cr | |||||
Merger & Related Restructuring Charges | -17Cr | -14Cr | -4.5Cr | -28Cr | -33Cr | |||||
Gain (Loss) On Sale Of Investments | 20Cr | -50Cr | -7.8Cr | -273.7Cr | -2.4Cr | |||||
Gain (Loss) On Sale Of Assets | - | 166.2Cr | -149.9Cr | 2.4Cr | 1.3Cr | |||||
Legal Settlements | 2.7Cr | 2.8Cr | -20Cr | - | 1.7Cr | |||||
Other Unusual Items | -14Cr | - | - | - | - | |||||
EBT, Incl. Unusual Items | 678.2Cr | 835.3Cr | 551.3Cr | 526.9Cr | 778.1Cr | |||||
Income Tax Expense | 136.7Cr | 160.7Cr | 14Cr | 149.1Cr | 149.3Cr | |||||
Earnings From Continuing Operations | 541.5Cr | 674.6Cr | 537.2Cr | 377.8Cr | 628.8Cr | |||||
Net Income to Company | 541.5Cr | 674.6Cr | 537.2Cr | 377.8Cr | 628.8Cr | |||||
Minority Interest | -5Cr | -7.8Cr | -21Cr | -34Cr | -33Cr | |||||
Net Income - (IS) | 536.5Cr | 666.8Cr | 516.4Cr | 343.4Cr | 595.7Cr | |||||
Net Income to Common Incl Extra Items | 536.5Cr | 666.8Cr | 516.4Cr | 343.4Cr | 595.7Cr | |||||
Net Income to Common Excl. Extra Items | 536.5Cr | 666.8Cr | 516.4Cr | 343.4Cr | 595.7Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 15.87 | 21.54 | 17.57 | 12.25 | 22.33 | |||||
Basic EPS - Continuing Operations | 15.87 | 21.54 | 17.57 | 12.25 | 22.33 | |||||
Basic Weighted Average Shares Outstanding | 34Cr | 31Cr | 29Cr | 28Cr | 27Cr | |||||
Net EPS - Diluted | 15.73 | 21.3 | 17.39 | 12.12 | 22.18 | |||||
Diluted EPS - Continuing Operations | 15.73 | 21.3 | 17.39 | 12.12 | 22.18 | |||||
Diluted Weighted Average Shares Outstanding | 34Cr | 31Cr | 30Cr | 28Cr | 27Cr | |||||
Normalized Basic EPS | 12.87 | 14.52 | 15.43 | 17.18 | 19.5 | |||||
Normalized Diluted EPS | 12.75 | 14.35 | 15.27 | 17.01 | 19.37 | |||||
Dividend Per Share | 4 | 4.48 | 4.92 | 5.6 | 6.04 | |||||
Payout Ratio | 25 | 20.76 | 28.08 | 45.63 | 27.04 | |||||
American Depositary Receipts Ratio (ADR) | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |||||
Supplemental Items | ||||||||||
EBITDA | 995.7Cr | 1.03TCr | 1.08TCr | 1.14TCr | 1.2TCr | |||||
EBITA | 970.4Cr | 1.01TCr | 1.05TCr | 1.12TCr | 1.18TCr | |||||
EBIT | 815.6Cr | 847.8Cr | 898.8Cr | 969.2Cr | 1.03TCr | |||||
EBITDAR | 1.02TCr | 1.05TCr | 1.1TCr | - | - | |||||
Total Revenues (As Reported) | 17TCr | 18TCr | 20TCr | 25TCr | 27TCr | |||||
Effective Tax Rate - (Ratio) | 20.16 | 19.24 | 2.56 | 28.3 | 19.19 | |||||
Current Domestic Taxes | 138Cr | 186.8Cr | 163.9Cr | 133.8Cr | 98Cr | |||||
Current Foreign Taxes | 21Cr | 22Cr | 16Cr | 25Cr | 19Cr | |||||
Total Current Taxes | 158.7Cr | 208.7Cr | 180Cr | 158.6Cr | 116.7Cr | |||||
Deferred Domestic Taxes | -29Cr | -45Cr | -61Cr | -16Cr | -12Cr | |||||
Deferred Foreign Taxes | 6.9Cr | -2.8Cr | -104.6Cr | 6.4Cr | 45Cr | |||||
Total Deferred Taxes | -22Cr | -48Cr | -165.9Cr | -9.5Cr | 33Cr | |||||
Normalized Net Income | 434.81Cr | 449.39Cr | 453.45Cr | 481.66Cr | 520.09Cr | |||||
Interest on Long-Term Debt | 20L | 20L | 40L | - | - | |||||
Non-Cash Pension Expense | -5.5Cr | -4.3Cr | 5.2Cr | -1.3Cr | 20L | |||||
Supplemental Operating Expense Items | ||||||||||
Net Rental Expense, Total | 21Cr | 16Cr | 15Cr | - | - | |||||
Imputed Operating Lease Interest Expense | 5.52Cr | 4.66Cr | 5.45Cr | - | - | |||||
Imputed Operating Lease Depreciation | 15Cr | 12Cr | 9.85Cr | - | - | |||||
Stock-Based Comp., SG&A Exp. (Total) | 18Cr | 17Cr | 22Cr | 24Cr | 20Cr | |||||
Stock-Based Comp., Other (Total) | 8.5Cr | 9.7Cr | 6.6Cr | 7Cr | 8.8Cr | |||||
Total Stock-Based Compensation | 27Cr | 26Cr | 29Cr | 31Cr | 29Cr |
- Stock Market
- Equities
- CI Stock
- Financials Cigna
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















